{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:39:01Z","timestamp":1786649941916,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Palliative care is a multidisciplinary approach aimed at improving the quality of life (QoL) and alleviating sufferings of people with serious and terminal illnesses. The present health system understands that palliative and rehabilitative services offer care to patients when cure is not possible. The concept is relatively new for most Indian graduates due to little emphasis on palliative care in the medical curriculum in India. Although palliative care has been incorporated in Universal Health Coverage in India and now also in the new competency-based medical curriculum in various subjects, including pharmacology, by the National Medical Commission, it is seldom emphasized to medical undergraduates in a structured, separate chapter. Like many other countries, it largely lacks implementation due to a lack of information and emphasis in standard textbooks. Palliative care is considered to be part of the primary healthcare system, and our budding physicians are supposed to be empowered with the prescription skills in palliative care. In the Indian scenario, this is being adopted newly in the medical training of primary care with the new medical education system. Pharmacology plays an important role in understanding the use of palliative care medicines. Palliative care pharmacology includes the use of various medications that target specific symptoms or conditions, for example, opioids such as morphine, fentanyl, and oxycodone for severe pain, antiemetics to alleviate nausea and vomiting, and benzodiazepines to manage anxiety and agitation. Most of the drugs prescribed in palliative care are usually covered in pharmacology textbooks, but in a \u201cpiecemeal.\u201d However, an explicit chapter on palliative care with the relevant pharmacology helps the young medicos to get sensitized to the drugs and acquire the requisite prescription skills early on the same go. \u201cStrength, weakness, opportunity, and threat analysis\u201d is a tool for strategic planning to assess the intrinsic and extrinsic factors, as well as the existing and upcoming potential of an initiative. Palliative care, which is relatively a new concept for MBBS teaching in India, is still at a primitive stage and needs more emphasis to provide definite advantages with the changing needs of society. Here, in a fresh perspective, through this fact-based analysis we looked at competitive position of \u2018Pharmacology\u2019 discipline to provide the early exposure of \u2018palliative care\u2019 to the MBBS students through a new chapter. We also explored its current relevance and future potential. In addition, we analyzed the internal and external factors influencing this approach, including its strengths, weaknesses, opportunities, and threats.<\/jats:p>","DOI":"10.4103\/ijp.ijp_474_24","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:00:15Z","timestamp":1767801615000},"page":"3-10","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Inclusion of \u201cpalliative care pharmacology\u201d as a new chapter in the pharmacology textbook for medical undergraduate students: A strength, weakness, opportunity, and threat analysis"],"prefix":"10.4103","volume":"58","author":[{"given":"Aditi","family":"Chaturvedi","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Pandit Jawahar Lal Nehru Government Medical College, Chamba, Himachal Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip","family":"Mukhopadhyay","sequence":"additional","affiliation":[{"name":"ICMR-National Institute for Research in Bacterial Infections, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rangeel Singh","family":"Raina","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Government Medical College, Haridwar, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurpreet","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Graphic Era Hill University, Dehradun, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"R2-20260109","doi-asserted-by":"crossref","first-page":"e000321","DOI":"10.1136\/openhrt-2015-000321","article-title":"Estimated incidence and risk factors of sudden unexpected death","volume":"3","author":"Lewis","year":"2016","journal-title":"Open Heart"},{"key":"R3-20260109","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/15360288.2018.1513435","article-title":"Adverse drug reactions in palliative care","volume":"32","author":"O'Leary","year":"2018","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"R5-20260109","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1080\/17425255.2016.1179281","article-title":"Pharmacokinetic considerations and recommendations in palliative care, with focus on morphine, midazolam and haloperidol","volume":"12","author":"Franken","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R6-20260109","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/cncr.22904","article-title":"Prevalence of Renal insufficiency in cancer patients and implications for anticancer drug management:The renal insufficiency and anticancer medications (IRMA) study","volume":"110","author":"Launay-Vacher","year":"2007","journal-title":"Cancer"},{"key":"R7-20260109","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0140-6736(17)32513-8","article-title":"Alleviating the access abyss in palliative care and pain relief-an imperative of universal health coverage:The lancet commission report","volume":"391","author":"Knaul","year":"2018","journal-title":"Lancet"},{"key":"R11-20260109","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1681\/ASN.2006050477","article-title":"Efficacy of the world health organization analgesic ladder to treat pain in end-stage renal disease","volume":"17","author":"Barakzoy","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R14-20260109","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2147\/JPR.S244173","article-title":"The modified WHO analgesic ladder:Is it appropriate for chronic non-cancer pain?","volume":"13","author":"Yang","year":"2020","journal-title":"J Pain Res"},{"key":"R15-20260109","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults:A systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol"},{"key":"R16-20260109","doi-asserted-by":"crossref","first-page":"977","DOI":"10.6004\/jnccn.2019.0038","article-title":"Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Swarm","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"R17-20260109","doi-asserted-by":"crossref","first-page":"E695","DOI":"10.1001\/amajethics.2020.695","article-title":"Revisiting the WHO analgesic ladder for surgical management of Pain","volume":"22","author":"McGuire","year":"2020","journal-title":"AMA J Ethics"},{"key":"R18-20260109","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.2217\/fon-2020-0834","article-title":"Low-Dose Olanzapine, Sedation and Chemotherapy-Induced Nausea and Vomiting:A Prospective Randomized Controlled Study","volume":"17","author":"Mukhopadhyay","year":"2021","journal-title":"Future Oncol"},{"key":"R19-20260109","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJMra1515442","article-title":"Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting","volume":"374","author":"Navari","year":"2016","journal-title":"N Engl J Med"},{"key":"R20-20260109","first-page":"100278","article-title":"Chemotherapy-induced nausea and vomiting:Pathogenesis, recommendations, and new trends","volume":"26","author":"Gupta","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"R21-20260109","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.2217\/fon-2020-0853","article-title":"Efficacy and safety of modafinil versus dexamethasone in cancer-related fatigue:a prospective randomized controlled study","volume":"17","author":"Deb","year":"2021","journal-title":"Future Oncol"},{"key":"R22-20260109","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0885-3924(92)90064-O","article-title":"Comprehensive and multidimensional assessment and measurement of pain","volume":"7","author":"McGuire","year":"1992","journal-title":"J Pain Symptom Manage"},{"key":"R23-20260109","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pmn.2021.11.002","article-title":"Pain management and risks associated with substance use:Practice recommendations","volume":"23","author":"Turner","year":"2022","journal-title":"Pain Manag Nurs"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.ijp_474_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:00:15Z","timestamp":1786647615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.ijp_474_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ijp.ijp_474_24","relation":{},"ISSN":["0253-7613","1998-3751"],"issn-type":[{"value":"0253-7613","type":"print"},{"value":"1998-3751","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2024-06-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}